tiprankstipranks
Trending News
More News >
Optimistic Buy Rating for Zevra Therapeutics Driven by Miplyffa Launch and Strategic Financial Moves
PremiumRatingsOptimistic Buy Rating for Zevra Therapeutics Driven by Miplyffa Launch and Strategic Financial Moves
2M ago
Zevra Therapeutics price target raised to $22 from $20 at Guggenheim
Premium
The Fly
Zevra Therapeutics price target raised to $22 from $20 at Guggenheim
2M ago
Zevra Therapeutics: Promising Outlook with Strong Financials and Strategic Focus on Rare Diseases
Premium
Ratings
Zevra Therapeutics: Promising Outlook with Strong Financials and Strategic Focus on Rare Diseases
2M ago
Zevra Therapeutics: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
PremiumRatingsZevra Therapeutics: Strong Financial Performance and Promising Growth Prospects Justify Buy Rating
2M ago
Zevra Therapeutics: Strong Financial Performance and Strategic Growth Justify Buy Rating
Premium
Ratings
Zevra Therapeutics: Strong Financial Performance and Strategic Growth Justify Buy Rating
2M ago
Zevra Therapeutics Reports 2024 Financial Results and Strategic Progress
Premium
Company Announcements
Zevra Therapeutics Reports 2024 Financial Results and Strategic Progress
2M ago
Zevra Therapeutics to sell Rare Pediatric Disease PRV for $150M
PremiumThe FlyZevra Therapeutics to sell Rare Pediatric Disease PRV for $150M
2M ago
ZVRA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ZVRA Earnings this Week: How Will it Perform?
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100